WallStreetZenWallStreetZen

NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jens HolsteinDirector2026-09-145,000$40.95
$204.75kSell
Rebecca ChambersCFO2026-09-041,175$43.71
$51.36kSell
Phillip G. FebboCSci2026-09-0410,405$42.89
$446.30kSell
Phillip G. FebboCSci2026-09-042,705$43.66
$118.11kSell
Annie McGuireCLO;EVP2026-09-041,100$43.67
$48.04kSell
Annie McGuireCLO;EVP2026-09-042,154$42.79
$92.17kSell
Rebecca ChambersCFO2026-09-042,477$42.81
$106.03kSell
Jonathan WygantCAO;VP2026-09-021,361$44.88
$61.08kSell
Phillip G. FebboCSci2026-09-023,639$44.88
$163.32kSell
Marc StapleyCEO2026-09-028,782$44.88
$394.14kSell

1 of 10

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Versant Ventures III LLC4.50%3,616,221$143.91MInsider
Brian G. Atwood4.50%3,616,221$143.91MInsider
Samuel D. Colella4.50%3,616,221$143.91MInsider
Brook H. Byers4.42%3,551,929$141.35MInsider
Tpg Group Holdings Sbs Advisors Inc4.42%3,551,929$141.35MInsider
Brian H. Dovey3.84%3,086,024$122.81MInsider
James C. Blair3.84%3,086,024$122.81MInsider
Brian K. Halak3.84%3,086,024$122.81MInsider
Kathleen K. Schoemaker3.84%3,086,024$122.81MInsider
Nicole Vitullo3.84%3,086,024$122.81MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT0.11%53.43%Net SellingNet Selling
DYN0.10%20.12%Net SellingNet Selling
ARQT0.10%30.68%Net SellingNet Selling
RCUS0.10%44.15%Net SellingNet Selling
DNLI0.10%57.28%Net SellingNet Selling
View Top Biotech Stocks

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 0.11% institutional shareholders, 53.43% Veracyte insiders, and 46.46% retail investors. Versant Ventures III LLC is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.50% of the company. Versant Ventures III LLC's Veracyte shares are currently valued at $143.91M.

If you're new to stock investing, here's how to buy Veracyte stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.